Can you provide the average price target for BLEND LABS INC-A stock?
13 analysts have analysed BLND and the average price target is 3.83 USD. This implies a price increase of 91.25% is expected in the next year compared to the current price of 2.
NYSE:BLND • US09352U1088
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BLEND LABS INC-A (BLND).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-11 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2026-03-11 | UBS | Maintains | Neutral -> Neutral |
| 2026-03-11 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-10 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-28 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-22 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-08 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-08-08 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-28 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-19 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-05-12 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-05-12 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-04-22 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-03-13 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-03 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-02-28 | UBS | Maintains | Neutral -> Neutral |
| 2025-02-28 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-12-20 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-12-18 | JMP Securities | Initiate | Market Outperform |
| 2024-12-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-11-07 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2024-11-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-11-07 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-11-07 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-10-23 | UBS | Maintains | Neutral -> Neutral |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 109.549M -53.42% | 115.762M 5.67% | 123.585M 6.76% | 139.84M 13.15% | 159.65M 14.17% | 184.55M 15.60% | |
| EBITDA YoY % growth | -121.088M 55.22% | -40.674M 66.41% | -17.576M 56.79% | 31.899M 281.49% | 49.233M 54.34% | N/A | |
| EBIT YoY % growth | -123.552M 56.06% | -42.963M 65.23% | -20.864M 51.44% | 24.822M 218.97% | 38.708M 55.94% | 48.112M 24.29% | |
| Operating Margin | -112.78% | -37.11% | -16.88% | 17.75% | 24.25% | 26.07% | |
| EPS YoY % growth | -0.42 46.15% | -0.08 80.95% | 0.01 112.50% | 0.08 692.23% | 0.15 85.14% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.01 -43.90% | 0.02 | 0.02 | 0.02 | 0.02 245.45% | 0.03 50.45% | 0.04 59.67% | 0.03 64.75% | 0.03 60.53% | 0.04 27.07% | 0.04 26.71% | 0.05 37.74% |
| Revenue Q2Q % growth | 30.13M 12.55% | 35.886M 13.84% | 37.415M 13.86% | 36.422M 12.52% | 35.921M 19.22% | 41.27M 15.00% | 43.541M 16.37% | 42.225M 15.93% | 42.106M 17.22% | 47.384M 14.81% | 50.465M 15.90% | 49.096M 16.27% |
| EBITDA Q2Q % growth | 3.071M 146.76% | 7.335M 306.68% | 7.727M 383.04% | 7.213M 707.15% | 6.599M 114.88% | 9.812M 33.77% | 11.327M 46.59% | 10.455M 44.95% | 13.403M 103.11% | 13.189M 34.42% | 16.891M 49.12% | 19.207M 83.71% |
| EBIT Q2Q % growth | 2.554M 136.62% | 6.526M 241.99% | 6.996M 245.21% | 6.427M 243.59% | 5.982M 134.22% | 9.803M 50.21% | 10.939M 56.36% | 10.394M 61.72% | 10.597M 77.15% | 14.404M 46.93% | 15.984M 46.12% | 15.889M 52.87% |
All data in USD
13 analysts have analysed BLND and the average price target is 3.83 USD. This implies a price increase of 91.25% is expected in the next year compared to the current price of 2.
The consensus EPS estimate for the next earnings of BLEND LABS INC-A (BLND) is 0.01 USD and the consensus revenue estimate is 30.13M USD.
The consensus rating for BLEND LABS INC-A (BLND) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.